Table 3.
Patient characteristics
| Gender n (%) | Female | 7 | (18.4) |
| Male | 31 | (81.6) | |
| Age (years) | Median | 70.7 | |
| Range | 47–88 | ||
| Clinical T stage n (%) | T2 | 11 | (28.9) |
| T3 | 18 | (47.4) | |
| T4 | 6 | (15.8) | |
| Prior cystectomy | 3 | (7.9) | |
| Pathological T stage n (%) | pT1 | 2 | (5.3) |
| pT2 | 30 | (78.9) | |
| pT3a/b | 0 | (0) | |
| pT4 | 2 | (5.3) | |
| Prior cystectomy | 3 | (7.9) | |
| Not known | 1 | (2.6) | |
| Clinical N stage n (%) | N0 | 16 | (42.1) |
| N1 | 9 | (23.7) | |
| N2 | 9 | (23.7) | |
| N3 | 4 | (10.5) | |
| Histology∗n (%) | Transitional cell | 33 | (86.8) |
| Small cell | 3 | (7.9) | |
| Squamous cell | 1 | (2.6) | |
| Not known | 1 | (2.6) | |
| Neoadjuvant chemotherapy n (%) | Yes | 31 | (81.6) |
| No | 7 | (18.4) | |
| Concurrent chemotherapy n (%) | Yes | 18 | (47.4) |
| No | 20 | (52.6) |
∗
All were high grade.